Gloria
González Aseguinolaza
Investigadora Senior
Rafael
Aldabe Arregui
Profesional Investigador
Publications by the researcher in collaboration with Rafael Aldabe Arregui (12)
2024
-
Deciphering the Role of Post-Translational Modifications and Cellular Location of Hepatitis Delta Virus (HDV) Antigens in HDV-Mediated Liver Damage in Mice
Viruses, Vol. 16, Núm. 3
-
Protective role of RIPK1 scaffolding against HDV-induced hepatocyte cell death and the significance of cytokines in mice
PLoS Pathogens, Vol. 20, Núm. 5
2022
-
Gene Therapy in Combination with Nitrogen Scavenger Pretreatment Corrects Biochemical and Behavioral Abnormalities of Infant Citrullinemia Type 1 Mice
International Journal of Molecular Sciences, Vol. 23, Núm. 23
2021
-
Aav-hdv: An attractive platform for the in vivo study of hdv biology and the mechanism of disease pathogenesis
Viruses, Vol. 13, Núm. 5
-
Novel vectors and approaches for gene therapy in liver diseases
JHEP Reports, Vol. 3, Núm. 4
-
Use of an adeno-associated virus serotype Anc80 to provide durable cure of phenylketonuria in a mouse model
Journal of Inherited Metabolic Disease, Vol. 44, Núm. 6, pp. 1369-1381
2020
-
TNF-alpha inhibition ameliorates HDV-induced liver damage in a mouse model of acute severe infection
JHEP Reports, Vol. 2, Núm. 3
2018
2017
-
A new HDV mouse model identifies mitochondrial antiviral signaling protein (MAVS) as a key player in IFN-β induction
Journal of Hepatology, Vol. 67, Núm. 4, pp. 669-679
2016
-
Transient expression of transgenic IL-12 in mouse liver triggers unremitting inflammation mimicking human autoimmune hepatitis
Journal of Immunology, Vol. 197, Núm. 6, pp. 2145-2156
2015
-
Animal models of chronic hepatitis delta virus infection host–virus immunologic interactions
Pathogens, Vol. 4, Núm. 1, pp. 46-65
2006
-
Gene therapy for viral hepatitis
Expert Opinion on Biological Therapy, Vol. 6, Núm. 12, pp. 1263-1278